Patient Informed Consent — ACCESS Model

Advancing Chronic Care with Effective, Scalable Solutions (CMMI / CMS) — Electronic Version

This document explains the CMS Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model and requests your voluntary agreement to participate. Cercanos Care is a participating organization under this 10-year initiative (July 5, 2026 – June 30, 2036), administered by the CMS Innovation Center (CMMI). Please read carefully and contact us with any questions before submitting your consent.

1. Purpose of This Consent

The ACCESS Model tests Outcome-Aligned Payments (OAPs) for technology-enabled, clinician-guided chronic care in Original Medicare. Cercanos Care will provide coordinated ongoing care for your chronic condition(s) using technology-enabled services that may include:

This program complements — it does not replace — your existing care team. Your primary care doctor or referring clinician will receive regular electronic updates on your progress.

2. Clinical Tracks — Qualifying Conditions

The ACCESS Model includes four initial clinical tracks. Your care team has identified the applicable track(s). Cercanos will be a participant of the three ACCESS model tracks listed below:

Track Qualifying Conditions
eCKM — Early Cardio-Kidney-Metabolic Hypertension; dyslipidemia; obesity/overweight with central adiposity; prediabetes
CKM — Cardio-Kidney-Metabolic Diabetes mellitus; chronic kidney disease (Stage 3a–3b); atherosclerotic cardiovascular disease
BH — Behavioral Health Depression and/or anxiety disorders

Note: You may not be enrolled in both eCKM and CKM simultaneously. You may participate in multiple tracks with the same or different ACCESS organizations.

3. Your Rights as a Participant

4. Data Use and Privacy

To deliver care under the ACCESS Model, Cercanos Care will:

All data exchange is conducted in compliance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and applicable federal and state privacy laws. For full details, refer to Cercanos Care’s Notice of Privacy Practices.

5. Technology-Enabled Services

As part of your ACCESS Model care, you may be asked to use one or more of the following technology tools:

Specific tools are determined clinically and will be discussed with you separately. You are not required to use any particular technology as a condition of enrollment.

6. Payment Information

You will not receive any financial payment or incentive for participating. Cercanos Care has selected to waive your Medicare cost-sharing amount for ACCESS-covered services.

7. Disenrollment and Switching

You may disenroll from the ACCESS Model after 90 days from the start of your alignment period. To request disenrollment, contact Cercanos Care at the information below. You may also switch to a different ACCESS-participating organization offering the same clinical track, subject to the same 90-day rule.

Upon disenrollment, all standard Original Medicare benefits remain fully intact and you may seek care from any Medicare provider without restriction.

8. Required Clinical Exclusions

Certain medical conditions prevent enrollment in the ACCESS Model for patient safety reasons. If you have any of the conditions listed below for your applicable track, you may not be enrolled or may be disenrolled from the program. Your clinical team will validate these criteria before initiating services.

eCKM and CKM Tracks — Required Exclusions
BH Track (Behavioral Health) — Required Exclusions

9. Model Evaluation — Important Notice

The ACCESS Model will be evaluated using a federally-funded randomized design with beneficiary-level randomization. Before verifying your eligibility or enrolling you, Cercanos Care is required to inform you of the following:

The randomization ratio in the first year of the model is 90:10 (intervention:control). CMS will communicate your assignment to Cercanos Care through the Eligibility and Alignment APIs. If you are assigned to the control group, Cercanos Care will notify you using CMS-standardized language.

RFA Reference: ACCESS Model Request for Applications v1.1 — CMS Innovation Center — Last Modified February 12, 2026
This document must be retained in the patient’s record. Version: July 2026 — Cercanos Care Compliance Office

10. Electronic Consent and Acknowledgment

By completing the fields below and signing, I confirm that:


Auto
Draw your signature above using mouse or touch

Complete the section below only if signing on behalf of the patient as an authorized representative.

Contact Information

Cercanos Care
8600 NW 36th St, Suite 501 · Doral, FL 33166
Phone: 305-831-2358
Email: privacy@cercanoscare.com · www.cercanoscare.com

CMS ACCESS Model: https://innovation.cms.gov/innovation-models/access

If you have questions about this consent or would like more information, please contact us at privacy@cercanoscare.com.

Thank you for trusting Cercanos Care with your health.